CRSP Operating Cash Flow (Statement)
Crispr Therapeutics Ag · Operating Cash Flow (Statement)
CRSP Operating Cash Flow (Statement)
Latest reported-$83.50Mperiod ending
CRSP Quarterly Cash from Operations (-$1.58M → -$83.50M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
CRSP operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -83,498,000 | |
| -108,897,000 | |
| -92,553,000 | |
| -84,634,000 | |
| -113,880,000 | |
| -53,947,000 | |
| -50,031,000 | |
| -106,913,000 | |
| -95,582,000 | |
| 109,752,000 | |
| -96,073,000 | |
| -39,856,000 | |
| -133,245,000 | |
| 8,799,000 | |
| -113,328,000 | |
| -105,218,000 | |
| -141,956,000 | |
| -135,239,000 | |
| -86,038,000 | |
| -81,329,000 | |
| 807,002,000 | |
| -100,663,000 | |
| -81,212,000 | |
| -75,700,000 | |
| -29,279,000 | |
| -52,175,000 | |
| 3,376,000 | |
| 133,420,000 | |
| -36,382,000 | |
| -43,737,000 | |
| -28,372,000 | |
| -19,964,000 | |
| -25,215,000 | |
| -22,688,000 | |
| -14,842,000 | |
| -15,868,000 | |
| -15,975,000 | |
| -23,412,000 | |
| -19,416,000 | |
| -12,276,000 | |
| -13,604,000 | |
| -10,014,000 | |
| 69,004,000 | |
| -5,313,000 | |
| -2,680,000 | |
| -1,583,000 |